Zeotech Limited (ASX: ZEO) has released a Preliminary Feasibility Study (PFS) for its AusPozz™ Project, confirming the strong technical and economic potential of Australia’s first metakaolin manufacturing facility for the production of low-carbon concrete additives. The study marks a major milestone for Zeotech’s ambition to support Australia’s decarbonisation efforts and transform the construction materials landscape.

AIC Mines Limited (ASX: A1M) has reached a major funding milestone with the successful completion of a $55 million Placement and the signing of a US$40 million Prepayment Facility and Offtake Agreement with Trafigura. These capital moves form a cornerstone of the company’s strategy to expand the Eloise Processing Plant and develop the Jericho Copper Mine, paving the way for a significant lift in copper output.

West Cobar Metals Limited (ASX: WC1) has concluded a focused reverse circulation (RC) drilling program across its wholly owned Fraser Range Project in southern Western Australia. Situated 120 km north-east of Esperance, this region sits within the Biranup Zone—an important structural corridor adjacent to the Fraser Zone, host of the Nova-Bollinger nickel-copper deposit.

Amplia Therapeutics Limited (ASX: ATX) is entering a compelling phase in its clinical journey, as recent announcements reinforce the growing potential of its lead compound, narmafotinib (AMP945), in the fight against advanced pancreatic cancer(Figure 1). With news of two rare and confirmed complete responses emerging from the ongoing ACCENT trial, investors have reason to take notice. These outcomes are not only clinically remarkable—they may signal a turning point in one of

Wide Open Agriculture Ltd (ASX: WOA) has announced the successful extraction of high-purity lupin oil from initial processing trials (Figure 1). The milestone represents a significant technical and commercial step forward, offering both a new revenue stream and a path toward maximising the full value of its lupin feedstock.

The Calmer Co. International Limited (ASX: CCO) has delivered a standout FY25 performance, underpinned by strong revenue growth and strategic product expansion. With a preliminary unaudited revenue result exceeding AU$8 million—an 86% increase on FY24—the company continues to gain traction as a leader in the natural relaxation and alcohol-alternative space.  

EQ Resources Ltd (ASX: EQR) has released preliminary results from XRT ore sorting trials at its Wolfram Camp Project, revealing encouraging recovery and upgrade outcomes that reinforce its ambition to develop a regional tungsten hub in Far North Queensland.

AML3D Limited (ASX:AL3) is forging ahead on its expansion strategy with significant strides into both the United Kingdom and United States defence markets. A recent A$0.83 million contract with BAE Systems UK marks a strategic entry into the UK defence supply chain, with AML3D sourcing 8.5 tonnes of Nickel Aluminium Bronze (NAB) feedstock to support BAE’s feasibility program.

Mesoblast Limited (ASX:MSB; Nasdaq:MESO), the recognised global developer of allogeneic cellular medicines, has released an important update that reflects both regulatory momentum and commercial progress across its core programs in inflammatory diseases.

Announcement Completion of Acquisition and Operational Update Avira Resources Ltd (ASX: AVW)  has made a number of announcements over the...